General News
Rybelsus Demonstrates Cardiovascular Benefits for Diabetes Patients
News Summary Novo Nordisk has announced that its diabetes medication Rybelsus shows significant cardiovascular benefits in a recent clinical trial. The trial revealed that Rybelsus